Christen Standiford
Adult Health · Savannah, GANPI 1366751463
Payments from drug & device makers
Across 93 payments — averaging $28.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$559
- AstraZeneca$370
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$261
- Amgen$240
- Boehringer Ingelheim$125
- Abiomed$125
- plus $965 from 17 others
What the payments were for
- Food & beverage$2,645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $559 |
| AstraZeneca(2 entities) | 3 | $370 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $261 |
| Amgen | 3 | $240 |
| Boehringer Ingelheim | 1 | $125 |
| Abiomed | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Redhill Biopharma Inc. | 6 | $111 |
| Mayne Pharma Commercial LLC | 1 | $99 |
| Novo Nordisk | 1 | $97 |
| QOL Medical, LLC | 4 | $96 |
| Bayer | 1 | $92 |
| Janssen Scientific Affairs, LLC | 1 | $80 |
| Nestle Healthcare Nutrition Inc. | 3 | $64 |
| Braintree Laboratories, Inc. | 2 | $38 |
| Sanofi | 1 | $37 |
| Merck | 2 | $27 |
| Veloxis Pharmaceuticals, Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,645 in reported general payments places this provider in the 80th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 18 | $752 |
| Prednisone | 98 | $580 |
| Losartan Potassium | 15 | $399 |
| Atorvastatin Calcium | 52 | $353 |
| Doxazosin Mesylate | 35 | $257 |
| Hydralazine Hcl | 18 | $252 |
| Tamsulosin Hcl | 15 | $189 |
| Pantoprazole Sodium | 18 | $188 |
| Potassium Chloride | 11 | $162 |
| Carvedilol | 12 | $142 |
| Hydrochlorothiazide | 26 | $137 |
| Amlodipine Besylate | 37 | $136 |
| Gabapentin | 15 | $57 |
Paid to pharmacies, not to this prescriber.
Other adult health in Savannah
- Amanda MerrittSavannah$16K
- Karen MosesSavannah$11K
- Jennie VandenhoutenSavannah$10K
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.